Is Coca-Cola's Corporate Citizenship The Real Thing? A New Study Casts More Aspersions Than Light

By Chuck Dinerstein, MD, MBA — May 07, 2019
Observers claim that a study identified several clauses in old Coca-Cola research contracts, those that “could suppress ‘critical health information’ and indeed may have already done so.” And while “the documents contained no firm examples of Coca-Cola suppressing unfavorable research, … the study's authors say "what is important is that the provision exists."

Observers claim that a study identified several clauses in old Coca-Cola research contracts, those that “could suppress ‘critical health information’ and indeed may have already done so.” And while “the documents contained no firm examples of Coca-Cola suppressing unfavorable research, … the study's authors say "what is important is that the provision exists."

Debunking Due Date Myths: Harry Says Royal Baby 'A Little Bit Overdue'

By Jamie Wells, M.D. — May 07, 2019
Before any misinformation spreads, it's important to unpack the real significance of surpassing a due date for mother and infant.

Before any misinformation spreads, it's important to unpack the real significance of surpassing a due date for mother and infant.

Environmental Working Group Serves Up More Nonsense: 'Organic: The Original Clean Food'

By Josh Bloom — May 07, 2019
"Two lawyers, a zoologist, and a nutritionist walk into a bar to try to write about chemistry." The preceding statement is true, except for the bar. The Environmental Working Group, with the aid of these four experts, wants to tell us how all the chemicals in food are going to lead us to an early dirt nap. They get an F in chemistry. As usual.

"Two lawyers, a zoologist, and a nutritionist walk into a bar to try to write about chemistry." The preceding statement is true, except for the bar. The Environmental Working Group, with the aid of these four experts, wants to tell us how all the chemicals in food are going to lead us to an early dirt nap. They get an F in chemistry. As usual.

Neurontin: The Darling of the Anti-Opioid Crowd. But Does It Work?

By Josh Bloom — May 07, 2019
The mad rush to rid this country of demonic prescription analgesic drugs (mainly Vicodin and Percocet) has put pain patients and their doctors in an unprecedented dilemma. What can they do for pain when real drugs are unavailable? Many have turned (or been forced to turn) to the epilepsy drug Neurontin, which is used off-label for pain. But does it work? Please read this and find out.

The mad rush to rid this country of demonic prescription analgesic drugs (mainly Vicodin and Percocet) has put pain patients and their doctors in an unprecedented dilemma. What can they do for pain when real drugs are unavailable? Many have turned (or been forced to turn) to the epilepsy drug Neurontin, which is used off-label for pain. But does it work? Please read this and find out.

Are Medical Journals No-Spin Zones? Not as Often as We Might Want

By Chuck Dinerstein, MD, MBA — May 06, 2019
Two studies look at how you can use words to spin non-significant findings into published studies, and how falsified data spreads unchecked from one meta-analysis to another.

Two studies look at how you can use words to spin non-significant findings into published studies, and how falsified data spreads unchecked from one meta-analysis to another.

Does Success Of 1st Organ Delivery Flight Make Drones A Realized Medical Moonshot?

By Jamie Wells, M.D. — May 06, 2019
Successful organ transplantation requires that a logistically complex series of events take place well beyond the scope of an ideally-matched donor and recipient. As the applications keep expanding, delivery-focused technology is a boon for healthcare.

Successful organ transplantation requires that a logistically complex series of events take place well beyond the scope of an ideally-matched donor and recipient. As the applications keep expanding, delivery-focused technology is a boon for healthcare.

A Closer Look at 'Anti-inflammatory' Diets

By David Lightsey MS — May 05, 2019
Certain foods, due to their effect on blood sugar levels, precipitate the release of molecules which are associated with inflammation. Excessive consumption of refined carbohydrates, french fries or soda isn't going to trigger that response. While those who eat this way may have significant negative health issues, it won't be due to so-called “inflammatory” foods. To suggest so is junk-science and a lack of common sense.

Certain foods, due to their effect on blood sugar levels, precipitate the release of molecules which are associated with inflammation. Excessive consumption of refined carbohydrates, french fries or soda isn't going to trigger that response. While those who eat this way may have significant negative health issues, it won't be due to so-called “inflammatory” foods. To suggest so is junk-science and a lack of common sense.

NRDC Never Stops Lying About Glyphosate, or Science in General

By Alex Berezow, PhD — May 03, 2019
Pop quiz: What do The New York Times, Jeffrey "the yogic flying instructor" Smith, and the National Resources Defense Council have in common? Answer: They all shamelessly lie about glyphosate to make money. (And you get extra credit if you answered "They are all bad sources of science information.")

Pop quiz: What do The New York Times, Jeffrey "the yogic flying instructor" Smith, and the National Resources Defense Council have in common? Answer: They all shamelessly lie about glyphosate to make money. (And you get extra credit if you answered "They are all bad sources of science information.")

A Panda’s Tale: Eat Like a Vegetarian, Thrive Like a Carnivore

By Chuck Dinerstein, MD, MBA — May 02, 2019
Are Giant pandas closer to bears or raccoons? It turns out that based on their eating habits, they share qualities of both. Perhaps pandas are not the vegetarians they seem to be.

Are Giant pandas closer to bears or raccoons? It turns out that based on their eating habits, they share qualities of both. Perhaps pandas are not the vegetarians they seem to be.

Antibiotics, Investors & Where We Go from Here

By David Shlaes — May 02, 2019
What do investors think about antibiotics companies? Not much. Paratek, priced at just $5.42, has a 36% short ratio -- or tradable shares being shorted by skeptical investors. Companies with market caps under $200 million do not bold well, either. Anyone who doubts that the antibiotic market is broken needs only ask the investors.

What do investors think about antibiotics companies? Not much. Paratek, priced at just $5.42, has a 36% short ratio -- or tradable shares being shorted by skeptical investors. Companies with market caps under $200 million do not bold well, either. Anyone who doubts that the antibiotic market is broken needs only ask the investors.